January 17, 2025 - 07:53

As tensions rise between China and the United States, investors in China are preparing for another round of economic challenges reminiscent of previous trade wars. The current climate is fraught with uncertainty as the yuan faces pressure along with the stock market, leading to concerns about potential repercussions on the broader economy.
The shifting dynamics in global trade relationships have prompted investors to reassess their strategies, particularly in light of the ongoing geopolitical strife. Analysts suggest that the ramifications of a renewed trade conflict could be far-reaching, affecting not only currency valuations but also investor confidence in the Chinese market.
With the yuan's stability under scrutiny, many are closely monitoring government responses and potential policy adjustments that may arise in the wake of these tensions. The stakes are high, as both nations navigate a complex landscape of tariffs, trade agreements, and economic policies that could redefine their economic futures. Investors are urged to remain vigilant as developments unfold in this critical economic battleground.
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...